Vascular dementia is caused by a defect on blood flow arrival to the brain, which consequently generates neuronal damage. Until now, its diagnosis has been quite complicated because only neuroimaging methods, such as a scanner, and the appearance of symptoms were available. The lack of more precise and specific methods creates confusion with other neurodegenerative diseases, like Alzheimer’s. A study, developed between Medical Center of Göttingen University (UMG) and Bellvitge Biomedical Research Institute (IDIBELL), has described a new biomarker for this disease, lipocalin 2 protein. This protein is present in the cerebrospinal fluid that bathes the brain.
Patient samples…
